DxS And Amgen Enter Into Collaboration To Provide A K-RAS Companion Diagnostic For Vectibix(R) In The United States
Dec 4th 2008Drug InformationColorectal Cancer
DxS, a personalised medicine company, has signed an agreement with Amgen Inc. to provide a K-RAS companion diagnostic for Vectibix® (panitumumab) in the United States.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
